PMID- 30993592 OWN - NLM STAT- MEDLINE DCOM- 20200824 LR - 20240204 IS - 1878-7479 (Electronic) IS - 1933-7213 (Print) IS - 1878-7479 (Linking) VI - 16 IP - 4 DP - 2019 Oct TI - Transcranial Magneto-Acoustic Stimulation Improves Neuroplasticity in Hippocampus of Parkinson's Disease Model Mice. PG - 1210-1224 LID - 10.1007/s13311-019-00732-5 [doi] AB - In this study, we have, for the first time, demonstrated the beneficial effects of transcranial magneto-acoustic stimulation (TMAS), a technique based on focused ultrasound stimulation within static magnetic field, on the learning and memory abilities and neuroplasticity of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease (PD). Our results showed that chronic TMAS treatment (2 weeks) improved the outcome of Morris water maze, long-term potentiation (LTP), and dendritic spine densities in the dentate gyrus (DG) region of the hippocampus of PD model mice. To further investigate into the underlying mechanisms of these beneficial effects by TMAS, we quantified the proteins in the hippocampus that regulated neuroplasticity. Results showed that the level of postsynaptic density protein 95 was elevated in the brain of TMAS-treated PD model mice while the level of synaptophysin (SYP) did not show any change. We further quantified proteins that mediated neuroplasticity mechanisms, such as brain-derived neurotrophic factor (BDNF) and other important proteins that mediated neuroplasticity. Results showed that TMAS treatment elevated the levels of BDNF, cAMP response element-binding protein (CREB), and protein kinase B (p-Akt) in the PD model mouse hippocampus, but not in the non-PD mouse hippocampus. These results suggest that the beneficial effects on the neuroplasticity of PD model mice treated with TMAS could possibly be conducted through postsynaptic regulations and mediated by BDNF. FAU - Wang, Yuexiang AU - Wang Y AD - College of Medicine, State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University, Tianjin, 300071, China. FAU - Feng, Lina AU - Feng L AD - College of Medicine, State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University, Tianjin, 300071, China. FAU - Liu, Shikun AU - Liu S AD - Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China. FAU - Zhou, Xiaoqing AU - Zhou X AD - Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China. FAU - Yin, Tao AU - Yin T AD - Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China. FAU - Liu, Zhipeng AU - Liu Z AD - Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300192, China. lzpeng67@163.com. FAU - Yang, Zhuo AU - Yang Z AUID- ORCID: 0000-0001-5212-0053 AD - College of Medicine, State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Tumor Microenvironment and Neurovascular Regulation, Nankai University, Tianjin, 300071, China. zhuoyang@nankai.edu.cn. LA - eng PT - Journal Article PL - United States TA - Neurotherapeutics JT - Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics JID - 101290381 SB - IM EIN - Neurotherapeutics. 2019 Jul 9;:. PMID: 31290089 MH - Acoustic Stimulation/*methods MH - Animals MH - Hippocampus/pathology/*physiology MH - Male MH - Maze Learning/physiology MH - Mice MH - Mice, Inbred C57BL MH - Neuronal Plasticity/*physiology MH - Parkinsonian Disorders/pathology/*physiopathology/*therapy MH - Transcranial Magnetic Stimulation/*methods PMC - PMC6985386 OTO - NOTNLM OT - Transcranial magneto-acoustic stimulation (TMAS) OT - brain-derived neurotrophic factor (BDNF) OT - dendritic spine OT - hippocampus OT - long-term potentiation (LTP) EDAT- 2019/04/18 06:00 MHDA- 2020/08/25 06:00 PMCR- 2020/10/01 CRDT- 2019/04/18 06:00 PHST- 2019/04/18 06:00 [pubmed] PHST- 2020/08/25 06:00 [medline] PHST- 2019/04/18 06:00 [entrez] PHST- 2020/10/01 00:00 [pmc-release] AID - S1878-7479(23)00977-7 [pii] AID - 732 [pii] AID - 10.1007/s13311-019-00732-5 [doi] PST - ppublish SO - Neurotherapeutics. 2019 Oct;16(4):1210-1224. doi: 10.1007/s13311-019-00732-5.